Ranking Alexa Global: # 8,981,454
Server:Apache/2.4.10 (Debia...
The main IP address: 138.201.189.93,Your server Germany,Berlin ISP:Hetzner Online AG TLD:com CountryCode:DE
The description :neovii is a global leader in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology/oncology. our lead product, grafalon®, has been used for over 30 years to treat ...
This report updates in 30-Jul-2018
Created Date: | 2013-02-15 |
Changed Date: | 2018-07-18 |
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host neovii.com. Currently, hosted in Germany and its service provider is Hetzner Online AG .
Latitude: | 52.524368286133 |
Longitude: | 13.410530090332 |
Country: | Germany (DE) |
City: | Berlin |
Region: | Berlin |
ISP: | Hetzner Online AG |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache/2.4.10 (Debian) containing the details of what the browser wants and will accept back from the web server.
Content-Length: | 5713 |
Content-Encoding: | gzip |
Vary: | Accept-Encoding |
Keep-Alive: | timeout=5, max=100 |
Server: | Apache/2.4.10 (Debian) |
Last-Modified: | Sun, 29 Jul 2018 16:54:55 GMT |
Connection: | Keep-Alive |
Date: | Sun, 29 Jul 2018 17:18:01 GMT |
Content-Type: | text/html; charset=UTF-8 |
soa: | ns1.your-server.de. postmaster.your-server.de. 2018071123 86400 10800 3600000 86400 |
txt: | "MS=ms82592843" "v=spf1 include:spf.protection.outlook.com a:nextcloud.neovii.com ip4:138.201.189.93 -all" |
ns: | ns3.second-ns.de. ns.second-ns.com. ns1.your-server.de. |
ipv4: | IP:138.201.189.93 ASN:24940 OWNER:HETZNER-AS, DE Country:DE |
mx: | MX preference = 1, mail exchanger = neovii-com.mail.protection.outlook.com. |
home about us our history our leadership team therapeutic areas stem cell transplantation graft-versus-host disease (gvhd) solid organ transplantation aplastic anemia autoimmune diseases medical professionals research & development partnership news & events next i careers vacancies employee portraits employee benefits contact effective antibody therapies our products are the result of the extensive experience, expertise, and commitment of many employees and partners throughout the world. targeted cancer and rejection treatments with our effective antibody therapies, we specifically influence the body’s immune system to fight malignant cells and to improve transplant tolerance. innovation and optimization of existing products solving unmet medical needs through continued development of new and existing antibody technologies. creating the future together find out more about our focus areas and offers for our partners. we look forward to shaping the future with you. welcome to neovii neovii is a global leader in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology/oncology. our lead product, grafalon ® , has been used for over 30 years to treat patients and is available in over 50 countries world wide. it has approval for use in immunosuppressive therapies for prevention of graft- versus- host disease in stem cell transplantation, prevention and treatment of rejection in solid organ transplantation and in treatment of aplastic anemia. there are differences in approved indications between countries so please refer to local country information for details. legal disclaimer privacy policy sitemap datenschutzhinweise neovii biotech gmbh the products presented on this website may not be approved, licensed or available in all countries. please contact us if you require specific information. this site uses cookies. by continuing to browse the site you are agreeing to our use of cookies. ok, i accept deny, leave page more information
https://neovii.com/therapeutic-areas/aplastic-anemia/
https://neovii.com/about-us/our-leadership-team/
https://neovii.com/about-us/our-history/
https://neovii.com/careers/
https://neovii.com/therapeutic-areas/graft-versus-host-disease-gvhd/
https://neovii.com/sitemap/
https://neovii.com/therapeutic-areas/stem-cell-transplantation/
https://neovii.com/therapeutic-areas/medical-professionals/
https://neovii.com/privacy-policy/
https://neovii.com/legal-disclaimer/
https://neovii.com/therapeutic-areas/
https://neovii.com/careers/job-offers/
https://neovii.com/contact/
https://neovii.com/news-events/
https://neovii.com/news-events/next-i/
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Domain Name: NEOVII.COM
Registry Domain ID: 1780480371_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.your-server.de
Registrar URL: http://www.hetzner.com
Updated Date: 2018-07-18T04:45:20Z
Creation Date: 2013-02-15T07:21:31Z
Registry Expiry Date: 2022-02-15T07:21:31Z
Registrar: Hetzner Online GmbH
Registrar IANA ID: 828
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +49 9831 5050
Domain Status: ok https://icann.org/epp#ok
Name Server: NS.SECOND-NS.COM
Name Server: NS1.YOUR-SERVER.DE
Name Server: NS3.SECOND-NS.DE
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-07-29T17:17:51Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR Hetzner Online GmbH
SERVERS
SERVER com.whois-servers.net
ARGS domain =neovii.com
PORT 43
TYPE domain
DOMAIN
NAME neovii.com
CHANGED 2018-07-18
CREATED 2013-02-15
STATUS
ok https://icann.org/epp#ok
NSERVER
NS.SECOND-NS.COM 213.239.204.242
NS1.YOUR-SERVER.DE 213.133.106.251
NS3.SECOND-NS.DE 193.47.99.4
REGISTERED yes
The following list shows you to spelling mistakes possible of the internet users for the website searched .